Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 2Thrombocythemia, Essential 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Prostatic Neoplasms 1Primary Myelofibrosis 1Polycythemia Vera 1Pinealoma 1Pancreatic Cancer Metastatic 1Osteosarcoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Myeloproliferative Disorders 1Medulloblastoma 1Leukemia, Myelomonocytic, Chronic 1Histiocytosis, Langerhans-Cell 1Ependymoma 1Carcinoma 1Brain Neoplasms 1

Interventions

chloroquine diphosphate 1balstilimab 1Taxes 1Gemcitabine 1Cisplatin 1Chloroquine 1Celecoxib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Pancreatic Cancer Metastatic × Celecoxib × Clear all
NCT06076837 2026-01-12

The Seven Trial: Exploiting the Unfolded Protein Response

HonorHealth Research Institute

Phase 1 Active not recruiting
6 enrolled
Gastrointestinal

Pancreatic Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡